2080
We have safely used recombinant factor VIIa to treat bleeding in the immediate and long-term period following PCC-related MI.
 PCC-related MI: Subject; PCC-related MI: Subject.Disorder; recombinant factor VIIa: Treatment; bleeding: Treatment.Disorder; immediate and long-term period: Treatment.Time_elapsed; recombinant factor VIIa: Treatment.Drug
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: potential therapeutic event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Treatment.Time_elapsed, Subject.Disorder, Subject.Race, Treatment.Route, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 PCC-related MI: Subject; PCC-related MI: Subject.Disorder; recombinant factor VIIa: Treatment; bleeding: Treatment.Disorder; immediate and long-term period: Treatment.Time_elapsed; recombinant factor VIIa: Treatment.Drug